If you have been reading about insulin-like growth factor 1 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-03-10. Numbers and descriptions here follow the published literature rather than marketing material.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone family and contains the same forty-four amino acid sequence as endogenous GHRH, extended at the amino terminus by a trans-3-hexenoyl group. That small fatty acid modification protects the peptide from rapid cleavage by dipeptidyl peptidase-4, the enzyme that shortens the half-life of native GHRH to only a few minutes. Chemically the compound is produced by solid-phase peptide synthesis, purified by chromatography, and supplied as a sterile lyophilized powder for reconstitution.
Regulatory approval in the United States came in 2010, when the Food and Drug Administration cleared the peptide for the reduction of excess abdominal fat in adults with HIV infection and associated lipodystrophy. The decision rested mainly on two randomized phase 3 trials that enrolled roughly eight hundred patients and ran for twenty-six weeks. Participants receiving active drug showed substantially greater declines in visceral adipose tissue than those receiving placebo, while total body weight changed comparatively little. A reformulated presentation was later approved, and the product has remained a niche therapy rather than a general weight-loss agent.
Tesamorelin occupies a narrow position among agents that act on the growth hormone axis. Unlike growth hormone itself, which is given as replacement, it stimulates the pituitary to release the hormone in pulses, so the downstream increase in insulin-like growth factor 1 depends on intact somatotroph function. Other peptides in the same family include shorter GHRH fragments and synthetic secretagogues with different stability profiles. Several points remain unresolved, including whether the reduction in visceral fat translates into fewer cardiovascular events, what happens to metabolic markers after long-term use, and how the drug compares with lifestyle or surgical approaches.
Stimulated growth hormone release leads to hepatic production of insulin-like growth factor 1, a key mediator of many growth hormone effects. In clinical studies, tesamorelin increased IGF-1 levels in a dose-dependent manner, although the response varies among individuals. The drug's effect on visceral fat is thought to involve growth hormone-mediated lipolysis and altered adipocyte metabolism. Muscle mass and lean body mass have also been assessed as secondary outcomes, but changes are generally smaller and less consistent than fat reductions.
Pharmacodynamic studies show that tesamorelin reduces visceral adipose tissue more than subcutaneous adipose tissue in the studied population. This selectivity may relate to differences in blood flow and hormone sensitivity between fat depots. Effects on glucose metabolism and insulin sensitivity have been investigated, with some trials reporting modest changes and others showing stability. The precise relationship between growth hormone exposure, IGF-1 levels, and visceral fat loss remains an active area of analysis.
Tesamorelin binds to growth hormone-releasing hormone receptors on somatotroph cells in the anterior pituitary. Receptor activation increases intracellular cyclic AMP and promotes synthesis and secretion of growth hormone. Because the peptide mimics endogenous GHRH, it amplifies the normal pulsatile release of growth hormone rather than providing exogenous growth hormone directly. This upstream action distinguishes tesamorelin from recombinant growth hormone preparations and from growth hormone secretagogues that act at different receptors.
| Property | Value | Notes |
|---|---|---|
| Peptide class | Synthetic GHRH analogue | 44 residues; N-terminal trans-3-hexenoyl group |
| First approval year | 2010 | United States; HIV-associated abdominal fat accumulation |
| Administration route | Subcutaneous injection | Abdominal site; clinician-administered or self-injected |
| Common synonyms | TH9507; tesamorelin acetate | Development code and acetate salt form |
| Originator | Canadian biotechnology firm | Original developer and regulatory sponsor |
A documented effect of tesamorelin is a reduction in visceral adipose tissue in some study populations. Researchers have reported decreases in trunk fat measured by computed tomography alongside changes in lipid markers. The mechanism is thought to involve growth hormone-mediated lipolysis, though the precise contribution of direct versus indirect pathways is not fully resolved. Studies have generally examined defined groups over finite periods, so long-term outcomes are less well characterized. Findings have not been uniform across all trials.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Its sequence corresponds to the 44-amino-acid form of human GHRH with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification slows enzymatic cleavage and extends the peptide's activity relative to the native hormone. The compound is produced by solid-phase peptide synthesis and supplied as a lyophilized powder. Researchers classify it as a GHRH receptor agonist. Its structure places it in the same family as other growth hormone secretagogues that act on the pituitary.
Binding of tesamorelin to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and the release of growth hormone into circulation. Because the peptide acts upstream of the growth hormone axis, its effects are partly mediated by hepatic insulin-like growth factor 1 (IGF-1) production. The pulsatile character of endogenous growth hormone secretion is preserved rather than replaced. Whether amplified signaling produces effects beyond those of native GHRH remains an area of ongoing investigation.
Insulin-like growth factor 1 is produced largely in the liver in response to growth hormone signaling. Its concentration shifts over days rather than minutes, which makes it practical for tracking changes across a study period. Interpretation still depends on age, nutritional status, and concurrent illness, all of which independently affect the marker. Reference ranges are therefore stratified, and comparisons are usually made within an individual over time rather than against a single population threshold.
Assays for these markers differ in calibration and antibody specificity, so results from different platforms are not always interchangeable. Reported values can shift when a laboratory changes method, even without any biological change. Studies that span long periods or multiple sites often need cross-validation of assays. This methodological variability is a recognized limitation when comparing findings across published reports, and it remains a topic of ongoing standardization work.
In chemistry, the molar mass (M) (sometimes called molecular weight or formula weight, but see related quantities for usage) of a chemical substance (element or compound) is defined as the ratio between the mass (m) and the amount of substance (n, measured in moles) of any sample of the substance: M = m/n. The molar mass is a bulk, not molecular, property of a substance. The molar mass is a weighted average of many instances of the element or compound, which often vary in mass due to the presence of isotopes. Most commonly, the molar mass is computed from the standard atomic weights and is thus a terrestrial average and a function of the relative abundance of the isotopes of the constituent atoms on Earth. The molecular mass (for molecular compounds) and formula mass (for non-molecular compounds, such as ionic salts) are commonly used as synonyms of molar mass, as the numerical values are identical (for all practical purposes), differing only in units (dalton vs. g/mol or kg/kmol). However, the most authoritative sources define it differently. The difference is that molecular mass is the mass of one specific particle or molecule (a microscopic quantity), while the molar mass is an average over many particles or molecules (a macroscopic quantity). The molar mass is an intensive property of the substance, that does not depend on the size of the sample. In the International System of Units (SI), the coherent unit of molar mass is kg/mol. However, for historical reasons, molar masses are almost always expressed with the unit g/mol (or equivalently in kg/kmol).
== Antagonists == Growth hormone receptor antagonists such as pegvisomant (trade name Somavert) are used in the treatment of acromegaly. They are used if the tumor of the pituitary gland causing the acromegaly cannot be controlled with surgery or radiation, and the use of somatostatin analogues is unsuccessful. Pegvisomant is delivered as a powder that is mixed with sterilized water and injected under the skin.
Following a 15-month ATP-commissioned investigation conducted by The Lake Forest Group (a third-party consultant working with the ATP's outside legal counsel, Smith Hulsey & Busey), the ATP announced in late January 2023 that they would not punish Zverev due to insufficient evidence to substantiate the allegations.
Throughout the civil war, Cossacks sometimes fought as an independent ally, and other times as an auxiliary, of White armies. In South Russia, the Armed Forces of South Russia (AFSR) under General Anton Denikin relied heavily on conscripts from the Don and Kuban Cossack Hosts to fill their ranks. Through the Cossacks, the White armies acquired experienced, skilled horsemen that the Red Army was unable to match until late in the conflict. But the relationship between Cossack governments and the White leaders was frequently acrimonious. Cossack units were often ill-disciplined, and prone to bouts of looting and violence that caused the peasantry to resent the Whites. In Ukraine, Kuban and Terek Cossack squadrons carried out pogroms against Jews, despite orders from Denikin condemning such activity. Kuban Cossack politicians, wanting a semi-independent state of their own, frequently agitated against the AFSR command. In the Russian Far East, anticommunist Transbaikal and Ussuri Cossacks undermined the rear of Siberia's White armies by disrupting traffic on the Trans-Siberian Railway and engaging in acts of banditry that fueled a potent insurgency in that region. As the Red Army gained the initiative in the civil war during late 1919 and early 1920, Cossack soldiers, their families, and sometimes entire stanitsas retreated with the Whites. Some continued to fight with the Whites in the conflict's waning stages in Crimea and the Russian Far East. As many as 80,000–100,000 Cossacks eventually joined the defeated Whites in exile.
Sources: en.wikipedia.org
== History == Setipiprant was initially researched by Actelion as a treatment for allergies and inflammatory disorders, particularly asthma, but despite being well tolerated in clinical trials and showing reasonable efficacy against allergen-induced airway responses in asthmatic patients, it failed to show sufficient advantages over existing drugs and was discontinued from further development in this application. However, following the discovery in 2012 that the prostaglandin D2 receptor (DP/PGD2) is expressed at high levels in the scalp of men affected by male pattern baldness, the rights to setipiprant were acquired by Kythera to develop the drug as a novel treatment for baldness. The favorable pharmacokinetics and relative lack of side effects seen in earlier clinical trials mean that fresh clinical trials for this new application can be conducted fairly quickly. As of 2015, setipiprant is currently under development by Allergan for the prevention of androgenic alopecia after their successful acquisition of Kythera.
==== Singapore ==== Chick-fil-A opened a pop-up restaurant at Esplanade Mall for three days from June 26 through 28, 2024, being the first Asian country to host a Chick-fil-A pop-up. On October 17, 2024, Chick-fil-A officially announced it would be opening in Singapore in late 2025, making the first Asian country to open the brand, and would be investing US$75 million into its first restaurant in the country for 10 years. The restaurant opened on December 11, 2025.
The order offered sickness and death insurance, assuring its members would be buried by Jewish law and become good American citizens. Order of United Hebrew Brothers - Founded in 1915. in 1917 was reported to have 1,800 members and 12 lodges in New York City. Orders stated objectives included promoting social intercourse, discussions of subjects relating to their community, and acting upon them. Provided free burials, helped members in distress, and encouraged enrollment in the Postal Life Insurance Company. United Order of True Sisters - Founded by Henrietta Bruckman, wife of a prominent New York doctor, with 12 other ladies to assist Hebrew housewives. Had 5,991 members in 21 lodges in 1918. Had 12,000 members in 1995. Headquarters in New York. National structure called "Grand Lodge". Has degrees, secret ritual regalia, etc. Originally German-speaking, the first English lodge was organized in 1892, by 1918 German language was "essentially discontinued in all lodges". Although originally a benevolent society for sick and widows, by the late 1970s, had become primarily a philanthropic group, particularly with cancer-related causes. The United Order True Sister Inc, Cancer Service created in 1947, contributes $300,000 a year to cancer patients and specialized care hospitals in 13 and Israel. Workmen's Circle
=== Metabolic/biochemical genetics === Metabolic (or biochemical) genetics involves the diagnosis and management of inborn errors of metabolism in which patients have enzymatic deficiencies that perturb biochemical pathways involved in metabolism of carbohydrates, amino acids, and lipids. Examples of metabolic disorders include galactosemia, glycogen storage disease, lysosomal storage disorders, metabolic acidosis, peroxisomal disorders, phenylketonuria, and urea cycle disorders.
when it maintains a charge q and travels through an electric field E and magnetic field B with a velocity v. The secondary ions that leave the surface of the sample typically have a kinetic energy of a few electron volts (eV), although a rather small portion have been found to have energy of a few keV. An electrostatic field captures the secondary ions that leave the sample surface; these extracted ions are then transferred to a mass spectrometer. In order to achieve precise isotope measurements, there is a need for high transmission and high mass resolution. High transmission refers to the low loss of secondary ions between the sample surface and the detector, and high mass resolution refers to the ability to efficiently separate the secondary ions (or molecules of interest) from other ions and/or ions of similar mass. Primary ions will collide with the surface at a specific frequency per unit of surface area. The collision that occurs causes atoms to sputter from the sample surface, and of these atoms only a small amount will undergo ionization. These become secondary ions, which are then detected after transfer through the mass spectrometer. Each primary ion generates a number of secondary ions of an isotope that will reach the detector to be counted. The count rate is determined by
Sources: en.wikipedia.org
Ambala district: Centre of Excellence for Litchi, announced in FY2025-26. Yamunanagar district: Centre of Excellence for strawberry, announced in FY2025-26. Karnal district: Centre of Excellence for Vegetables, Gharaunda, established 7.01.2011. Karnal district: Potato Technology Centre, Shamgarh, established 06.04.2016. Kurukshetra district: Centre for Subtropical Fruits, Ladwa, established 06.04.2016. Kurukshetra district: Horticulture Integrated Bee Keeping, Ram Nagar, post office Chaduni Jattan, established 10.11.2017. Rohtak district: Hi-tech Greenhouse Seedling Centre, established 17.12.2013. Jhajjar district: Center of Excellence for Flowers, Munimpur, established 2022. Gurugram district: Hi-tech Greenhouse Seedling Centre, established 17.12.2013. Nuh district: Center of Excellence for Onions, Pinangwan, established 2022. Palwal district: Integrated Horticulture Development, Centre, Hodal, established 13.10.2018. Mahendergarh district: Integrated Horticulture Development Centre, Sundrah village on Ateli-Kanina road, established 01.09.2019. Bhiwani district: Centre of excellence for semi-arid horticulture, Gignaw, established 2022. Hisar district: Multi Crops Demonstration Centre, Barwala, established 2022. Hisar district: Date Palm and Guava Demonstration Centre, announced in FY2025-26. Fatehabad district: Guava Demonstration Centre at Government Garden Nursery on Uklana road, Bhuna, established 27.10.2020. Sirsa district: Centre of Excellence for fruits (Citrus & Pomegranate), Mangiana, established 22.06.2013.
There is an ongoing opioid epidemic (also known as the opioid crisis) in the United States, originating out of both medical prescriptions and illegal sources. It has been described by doctors and researchers as "one of the most devastating public health catastrophes of our time". The opioid epidemic unfolded in three waves. The first wave of the epidemic in the United States began in the late 1990s, according to the Centers for Disease Control and Prevention (CDC), when opioids were increasingly prescribed for pain management, resulting in a rise in overall opioid use throughout subsequent years. The second wave was from an expansion in the heroin market to supply already addicted people. The third wave, starting in 2013, was marked by a steep tenfold increase in the synthetic opioid-involved death rate as synthetic opioids flooded the US market. In the United States, there were approximately 109,600 drug-overdose-related deaths in the 12-month period ending January 31, 2023, at a rate of 300 deaths per day. From 1999 to 2020, nearly 841,000 people died from drug overdoses, with prescription and illicit opioids responsible for 500,000 of those deaths. Drug overdose deaths totaled 70,237 in 2017, with 47,600 involving an opioid. This surpassed deaths from car crashes (37,133) by 28%. A December 2017 report estimated that 130 people die every day in the United States due to opioid-related drug overdose. The great majority of Americans surveyed in 2015 who used prescription opioids did not believe that they were misusing them.
== Treatment == Gilbert's syndrome is a benign condition that typically requires no medical treatment. The primary approach involves patient education and reassurance about the harmless nature of the syndrome. Episodes of jaundice, when they occur, are usually mild and resolve on their own without intervention. To minimize the frequency of these episodes, individuals are advised to avoid known triggers such as fasting, dehydration, stress, and strenuous physical exertion. Maintaining a healthy lifestyle, including regular meals and adequate hydration, can help manage the condition effectively. If jaundice is significant, phenobarbital may be used.
=== Prout's hypothesis and the whole number rule === The whole number rule states that the masses of the isotopes are integer multiples of the mass of the hydrogen atom. The rule is a modified version of Prout's hypothesis proposed in 1815, to the effect that atomic weights are multiples of the weight of the hydrogen atom.
Sources: en.wikipedia.org
It is a laboratory-made peptide of forty-four amino acids whose sequence matches human growth hormone-releasing hormone, with a modified amino terminus. The modification is a short unsaturated fatty acid chain attached to the first residue. This change slows enzymatic breakdown and lengthens the time the peptide stays active in circulation.
The clinical program was designed around HIV-associated lipodystrophy, a condition in which fat accumulates abnormally around the internal organs. Trials enrolled that specific population, so the evidence base covers it rather than the general population. Regulators approved the drug for the studied indication only, and promotion outside it is not permitted.
Growth hormone therapy supplies the finished hormone directly, while this peptide acts upstream and asks the pituitary to secrete its own. That difference means the response depends on a functioning pituitary and on the body's normal feedback loops. It also means the circulating hormone profile is pulsatile rather than a flat, injected level.
It targets the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Binding stimulates cyclic AMP signaling and growth hormone secretion. This is the same receptor used by endogenous GHRH.